Oncology History
1832, Thomas Hodgkin's publication in Medico-Chirurgical Transactions, London, England
Lymphoma, a cancer of the lymphatic system, has a medical history stretching back to early nineteenth-century European pathology, when physicians first began distinguishing diseases of the lymph nodes from other swellings of the body. The condition's recorded history is deeply intertwined with the development of pathological anatomy as a scientific discipline. Over more than two centuries, understanding of lymphoma evolved from vague anatomical observation to cellular classification, driven by pioneering figures whose work transformed oncology as a whole.
Historical Narrative
The story of lymphoma's medical history begins in earnest in 1832, when the English physician Thomas Hodgkin published a landmark paper titled 'On Some Morbid Appearances of the Absorbent Glands and Spleen' in the Medico-Chirurgical Transactions. In this paper, Hodgkin described post-mortem findings from seven patients whose lymph nodes and spleens had undergone dramatic enlargement. He was careful to distinguish these cases from inflammatory swellings, proposing that the changes he observed represented a primary disease of the lymphatic system rather than a secondary consequence of infection. At the time, his colleagues largely overlooked the work, and it was not until 1865 that the prominent physician Samuel Wilks revisited Hodgkin's original cases, confirmed and expanded upon the findings, and formally named the condition 'Hodgkin's Disease' in the earlier physician's honor.
Before Hodgkin's contribution, ancient and medieval physicians had no conceptual framework for distinguishing lymphatic malignancies from other forms of glandular swelling. Greek and Roman medical writers, including Galen, attributed enlarged lymph nodes to imbalances in the four humors, particularly an excess of black bile, which was understood to cause hard, dark swellings throughout the body. Medieval Islamic physicians such as Avicenna catalogued various forms of glandular enlargement in encyclopedic works like the Canon of Medicine, but these descriptions blended together what later generations would classify as distinct diseases, including tuberculosis, syphilis, and lymphatic cancers.
The microscopic era transformed the understanding of lymphoma dramatically. In 1878, the German pathologist Wilhelm Erb and later Carl Sternberg in 1898 identified a distinctive giant cell in the tissue of Hodgkin's disease patients. Dorothy Reed, an American pathologist working at Johns Hopkins, independently characterized the same cell in 1902 with exceptional precision, and these cells became permanently known as Reed-Sternberg cells, serving as a defining histological hallmark of Hodgkin's disease for generations of researchers.
The broader category of non-Hodgkin lymphomas took longer to crystallize as a coherent group. Theodore Billroth, the celebrated Austrian surgeon, was among the first to use the term 'malignant lymphoma' in 1871 to describe lymphatic tumors that did not fit the Hodgkin pattern. Throughout the late nineteenth and early twentieth centuries, European and American pathologists debated whether the various non-Hodgkin lymphatic tumors represented a single disease or a collection of related but distinct entities.
The twentieth century brought increasingly refined classification systems. In 1956, Henry Rappaport introduced an influential scheme that organized non-Hodgkin lymphomas by cellular architecture, a framework that guided clinical researchers for decades. His system was later debated and revised as immunological techniques revealed that lymphomas arose from distinct cell lineages within the immune system, a discovery that reshaped the entire conceptual foundation of lymphoma pathology.
The history of lymphoma is therefore a history of progressive refinement — from Hodgkin's careful bedside-to-morgue observations, through the microscopic revelations of Reed and Sternberg, to the immunological revolutions of the mid-twentieth century — each era adding new layers of understanding to one of medicine's most studied families of disease.
Key Historical Figures
Historical narrative only — this page describes how Lymphoma was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.